Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) was the target of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 2,210,000 shares, a decrease of 21.9% from the April 30th total of 2,830,000 shares. Based on an average trading volume of 1,010,000 […]
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) insider Alexandra Hughes-Wilson sold 100,432 shares of Mereo BioPharma Group stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $2.97, for a total transaction of $298,283.04. Following the sale, the insider now owns 32,568 shares in […]
Cantor Fitzgerald reissued their overweight rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Free Report) in a research report released on Thursday morning, Benzinga reports. Cantor Fitzgerald currently has a $7.00 target price on the stock. Separately, Needham & Company LLC reaffirmed a buy rating and set a $6.00 price objective on shares of […]
Bryn Mawr Capital Management LLC lessened its holdings in Dimensional U.S. Equity ETF (NYSEARCA:DFUS – Free Report) by 72.6% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,682 shares of the company’s stock after selling 20,323 shares during the quarter. Bryn Mawr Capital Management […]
Schwarz Dygos Wheeler Investment Advisors LLC lessened its position in Dimensional International Value ETF (NYSEARCA:DFIV – Free Report) by 4.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,021 shares of the company’s stock after selling 365 shares during the quarter. Schwarz Dygos Wheeler […]